Contact
Please use this form to send email to PR contact of this press release:
Immatics Receives USD 58 Million in Financing to Develop T-Cell Receptor Based Immunotherapies
TO:
Please use this form to send email to PR contact of this press release:
Immatics Receives USD 58 Million in Financing to Develop T-Cell Receptor Based Immunotherapies
TO: